ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00798460
Recruitment Status : Terminated (could not enroll patients)
First Posted : November 26, 2008
Last Update Posted : June 23, 2011
Sponsor:
Collaborator:
Bukwang Pharmaceutical
Information provided by:
Inje University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2010
  Actual Study Completion Date : November 2010